Vaginal Isonicotinic Acid Hydrazide Administration Prior to Intrauterine Device Insertion

IUCD Complication Clinical Trial

Official title:
Benefits of Self-administered Vaginal Isonicotinic Acid Hydrazide (INH) Administration 12 Hours Prior to Intrauterine Device Insertion in Adolescent and Young Women: a Randomized Controlled Trial

Status Completed

Clinical Trial Summary

To investigate whether vaginal isonicotinic acid hydrazide administered before the levonorgestrel-releasing intrauterine system insertion reduces IUD insertion pain and difficulty in insertion in adolescents and young women.

Clinical Trial Description

Long-acting reversible contraception methods are highly effective methods for reduction of the unplanned pregnancy rate worldwide. The intrauterine device is a single procedure that provides reliable, effective and long term contraception for many women. However, the insertion procedure can be associated with a troublesome degree of pain that prevent some women from choosing its use. Different interventions have been described to decrease pain perception during intrauterine device insertion with no agreement on an effective one. ;

Study Design

Related Conditions & MeSH terms

IUCD Complication

Clinical Trial Details

NCT number	NCT04500015
Study type	Interventional
Source	Aswan University Hospital
Contact
Status	Completed
Phase	Phase 4
Start date	September 1, 2020
Completion date	August 30, 2021

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04517890` - Transdermal Lidocaine Administration Prior to Insertion Levonorgestrel-releasing Intrauterine System	N/A
Completed	`NCT04505657` - Lidocaine Spray Plus Oral Celecoxib for Pain Control During Hysterosalpingography	N/A
Completed	`NCT04499989` - Vaginal Isonicotinic Acid Hydrazide (INH) Administration Prior to T380A Intrauterine Device Insertion	Phase 4
Not yet recruiting	`NCT04505917` - Vaginal Misoprostol and Dinoprostone Prior to Copper Intrauterine Device Insertion in Women	N/A
Not yet recruiting	`NCT04500002` - Isonicotinic Acid Hydrazide (INH) Pretreatment With Misoprostol Versus Misoprostol Alone in Missed Abortion	N/A
Not yet recruiting	`NCT04505943` - Vaginal Misoprostol and Dinoprostone and Isonicotinic Acid Hydrazide Prior to Copper Intrauterine Device Insertion	N/A
Completed	`NCT04500028` - Vaginal Isonicotinic Acid Hydrazide Administration Prior to Insertion Levonorgestrel-releasing Intrauterine System	Phase 4